BCRX

BCRX Stock-Based Compensation

$121.89MTTM · USD

Period ending:

BCRX FY Stock-Based CompUSD
BCRX FY Stock-Based Comp1994-12-31: $0.001995-12-31: $0.001996-12-31: $0.001997-12-31: $0.001998-12-31: $0.001999-12-31: $0.002000-12-31: $104.53M2001-12-31: $123.29M2002-12-31: $120.19M2003-12-31: $119.68M2004-12-31: $512.43M2005-12-31: $26.39M2006-12-31: $3.34B2007-12-31: $5.69B2008-12-31: $5.86B2009-12-31: $5.52M2010-12-31: $6.30M2011-12-31: $4.77M2012-12-31: $4.17M2013-12-31: $4.37M2014-12-31: $10.18M2015-12-31: $9.71M2016-12-31: $8.49M2017-12-31: $12.62M2018-12-31: $9.40M2019-12-31: $17.72M2020-12-31: $0.002021-12-31: $34.64M2022-12-31: $44.70M2023-12-31: $55.62M2024-12-31: $65.41M2025-12-31: $85.07M$5.86B$0.00
1994-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BCRX stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 32 observations from Dec 31, 1994 to Dec 31, 2025.

Biocryst Pharmaceuticals Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
85,066,000
65,413,000
55,615,000
44,701,000
34,640,000
0
17,719,000
9,396,000
12,621,000
8,487,000
9,705,000
10,177,000
4,368,000
4,167,000
4,772,000
6,301,856
5,524,883
5,860,654,000
5,691,028,000
3,338,761,000
26,392,000
512,427,000
119,676,000
120,190,000
123,289,000
104,529,000
0
0
0
0
0
0

Compare stock-based compensation

All BCRX financial metrics · BCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.